Bortezomib is a proteasome inhibitor used to take care of a number of myeloma in individuals who may have not been productively handled with at the very least two earlier therapies. chloramphenicol will enhance the degree or impact of bortezomib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of. https://le30009875.blogacep.com/31876711/5-easy-facts-about-dup-747-described